Holla L I, Stejskalova A, Vasku A
Department of Pathological Physiology, Medical Faculty, Masaryk University Brno, Brno, Czech Republic.
Allergy. 2006 Feb;61(2):265-7. doi: 10.1111/j.1398-9995.2006.01000.x.
Allergic diseases belong to the most common chronic disorders affecting mankind and their prevalence in population is increasing. Several studies have indicated that oxidative stress impairs pulmonary function and makes existing asthma worse. Members of the glutathione-S-transferase (GST) superfamily of genes are important in protection of cells from reactive oxygen species.
Relationships among allergic diseases including asthma and variations in the GST mu (GSTM1) and GST theta (GSTT1) genes were investigated in 1,006 Caucasian subjects.
The multiplex polymerase chain reaction protocol was used for simultaneous amplification of both genes for molecular analysis. Genotype frequencies among patients and controls were assessed and the associations of the genotypes with intermediary phenotypes of allergy were statistically determined.
The frequencies of GST null genotypes did not differ significantly between patients with allergic diseases (or asthma alone) and healthy controls. However, when compared with patients homozygous or heterozygous for GSTM1 functional allele, asthmatics carrying both GSTM1 null alleles displayed significantly worse lung function, assessed by forced expiratory volume in 1 s/forced vital capacity (FEV(1)/FVC) ratio (Tiffenau index), (P < 0.01).
Genetic polymorphisms of the GSTM1 and GSTT1 genes, both individually and in combination, were not associated with the development of allergic diseases including asthma in the Czech population, the GSTM1 gene variability, however, may influence lung functions in our asthmatics.
过敏性疾病是影响人类的最常见慢性疾病,其在人群中的患病率正在上升。多项研究表明,氧化应激会损害肺功能并使现有的哮喘病情加重。谷胱甘肽 - S - 转移酶(GST)基因超家族成员在保护细胞免受活性氧的侵害方面起着重要作用。
在1006名白种人受试者中研究包括哮喘在内的过敏性疾病与谷胱甘肽 - S - 转移酶μ(GSTM1)和谷胱甘肽 - S - 转移酶θ(GSTT1)基因变异之间的关系。
采用多重聚合酶链反应方案同时扩增这两个基因以进行分子分析。评估患者和对照组中的基因型频率,并统计确定基因型与过敏中间表型的关联。
过敏性疾病患者(或仅哮喘患者)与健康对照组之间GST无效基因型的频率没有显著差异。然而,与GSTM1功能等位基因纯合或杂合的患者相比,携带两个GSTM1无效等位基因的哮喘患者通过1秒用力呼气量/用力肺活量(FEV(1)/FVC)比值(蒂费诺指数)评估的肺功能明显更差,(P < 0.01)。
在捷克人群中,GSTM1和GSTT1基因的遗传多态性,无论是单独还是组合,都与包括哮喘在内的过敏性疾病的发生无关,然而,GSTM1基因变异性可能会影响我们哮喘患者的肺功能。